Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner
January 20th, 2023
R. Scott Turner A breakthrough, finally! Leqembi is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. Thus, Leqembi (previously…
MDP in the News
October 11th, 2022
The Memory Disorders Program’s own Clinical Trial Manager, Angelica Forero, was interviewed about a groundbreaking clinical trial at Georgetown using ‘nicotine’ to end memory loss. See the full…
Allegations of fraud in Alzheimer’s disease research- death of the amyloid hypothesis?
August 1st, 2022
R. Scott Turner, PhD, MD Recent reports of fraud in Alzheimer’s disease (AD) research have raised major concerns. Some of the figures in a highly-cited paper (using animal models of…
These Simple Tasks Can Cut Your Risk Of Dementia, Study Finds
August 1st, 2022
29 JULY 2022: Link to Huffington Post article…
Achieving Greater Diversity in Dementia Research: A Call to Action
June 30th, 2022
by R. Scott Turner and Charlyn Gomez: In the US, individuals in URGs are defined as Black or African-American, Hispanic/Latinx, Indigenous and Native American, Asian, Native Hawaiians and…
Nicotine to Help Treat Memory Loss?
June 30th, 2022
**Reference pg. A6 for article: A study funded by the National Institutes of health is testing whether the nicotine patch can improve memory and functioning in people who have mild memory loss or…
Memory Disorders Program Intern and First SCS Student Wins Lena Landegger Community Service Award
June 30th, 2022
For the first time, an SCS student has won Georgetown’s Lena Landegger Community Service award: James Jaramillo, a graduate of the Bachelor of Arts in Liberal Studies Program A graduate of the…
New Developments in Alzheimer’s Disease Therapeutics
December 2nd, 2021
R. Scott Turner, PhD, MD Memory Disorders Program, MedStar Georgetown University Hospital Nov. 18, 2021 Aducanumab (Aduhelm®) On June 7, 2021 the FDA granted accelerated approval of the…
Alzheimer’s Association On Demand Webinars
June 29th, 2021
View some free, on demand webinars regarding a variety of Alzheimer’s topics including Aducanmunab on the Alzheimer’s Association website. View…
Aducanumab (AduhelmTM) – the first disease-modifying treatment for Alzheimer’s disease approved by the US Food and Drug Administration, 7 June 2021
June 7th, 2021
Availability of Aduhelm remains unclear Coverage by Medicare and other third-party payers unknown More information to follow R. Scott Turner, PhD, MD, and the Memory Disorders Program On…
Brain Health in America: An Urgent Initiative
February 10th, 2021
A presentation by Stephanie Monroe The GUMC Memory Disorders Program was honored to host Stephanie Monroe, Executive Director of AfricanAmericansAgainstAlzheimer’s, who discusses Brain Health in…
Alz in the Fam: A Podcast Featuring Brigid Reynolds
July 29th, 2020
Episode 9 of Alz In The Fam features Brigid Reynolds – neurology provider at Georgetown University’s Memory Disorders Program. All four Fair siblings sit down with Brigid, their first ever guest, to discuss their Mom’s journey with Alzheimer’s!…
Slowly Breaking Ground in Alzheimer’s
May 14th, 2020
Like the disease itself, the study of Alzheimer’s takes time and patience. Georgetown researchers walk the long road to uncover the mysteries of memory and cognition in the aging brain.…
Adapting to the COVID-19 pandemic
May 12th, 2020
Receive Memory Disorders Program updates on our clinic and research operations, tips for caregivers helping loved ones cope with the pandemic, and COVID-19 resources. Slides from this…
Coronavirus Pandemic
March 20th, 2020
Memory Disorders Program Memo To our patients and their families: Thank you for your patience and understanding during difficult times while the entire community and we as research…
Study Researches Whether Nicotine Patch Can Help People With Memory Loss
February 18th, 2020
The clinical trial is the largest and longest of its kind, enrolling up to 300 people in 23 states to test the theory.…
Georgetown’s Alzheimer’s clinic marks 20 years, but hopes research can make it obsolete
January 17th, 2020
Alison Starling with WJLA visits Carolyn Ward, Program Coordinator at the Georgetown University Memory Disorders Program.…
A Four-Pillar Program to Preserve Brain Health
October 7th, 2019
A Four-Pillar Program to Preserve Brain Health provides guidelines on maintaining your memory. The program focuses on Physical Health, Emotional Health, Knowledge about your risk for neurological disease, and Actions you should take regarding your health.…
Where Are We in the Search for Better Treatments?
August 28th, 2019
Alzheimer’s Talks host Meryl Comer speaks with one of the nation’s leading Alzheimer’s disease researchers, Dr. R. Scott Turner, director of the Georgetown University Memory Disorders Program, about the current Alzheimer’s drug pipeline and related questions of diagnosis and prevention methods.…
Nicotine may help memory loss
August 27th, 2019
“Oddly a naturally occurring substance that we associate with bad outcomes like smoking, actually if we use it in a different way may turn out to be helpful for us,” said Dr. Newhouse.…
So Far, Just One Thing Has ‘Experimental Support’ In Staving Off Alzheimer’s
May 9th, 2019
“I tell people to go to the gym three to four times a week if they want to prevent Alzheimer’s.” And that along with a healthy diet may well be all we have for now in the wake of so many failed attempts at treating or curing the disease. Still, scientists like Dr. R. Scott Turner, who directs the Memory Disorders Program at Georgetown University Medical Center, are far from giving up the fight.…
Preparing For A Treatment: Alzheimer’s Diagnosis & Care
November 27th, 2018
The Hill will convene key lawmakers, health officials, industry stakeholders, researchers, physicians, patients, and their advocates to continue the conversation about preparing the American health care delivery system for the possibility of a groundbreaking advancement in the treatment of Alzheimer’s. Speakers include Dr. Raymond Turner from the MDP, Senator Ed Markey (D-MA), Senator Thom Tillis (R-NC).
Watch the event recording: ustream.tv/recorded/118452841…
Retired Supreme Court Justice Sandra Day O’Connor announces she is withdrawing from public life because of dementia
October 23rd, 2018
Retired Justice Sandra Day O’Connor revealed in a letter on Tuesday that she has been diagnosed with the “beginning stages of dementia, probably Alzheimer’s disease.”…
Studies in Healthy Older People Aim to Prevent Alzheimer’s
October 2nd, 2018
PHOENIX (AP) — It may be too late to stop Alzheimer’s in people who already have some mental decline. But what if a treatment could target the very earliest brain changes while memory and thinking skills are still intact, in hope of preventing the disease? Two big studies are going all out to try.…
Alzheimer’s Research Receives Largest Ever Funding Boost in 2019 Budget
September 28th, 2018
WASHINGTON, D.C., September 28, 2018 —The largest-ever funding increase for Alzheimer’s and dementia research at the National Institutes of Health (NIH) was signed into law today. The $425 million increase was advocated for by the Alzheimer’s Association, the Alzheimer’s Impact Movement (AIM) and its nationwide network of dedicated advocates.…
A healthier heart may mean a healthier mind, new study shows
July 25th, 2018
It turns out maintaining low blood pressure does not just help prevent heart attacks — it can also keep your mind sharp. Research presented Wednesday at the Alzheimer’s Association International Conference in Chicago found that at-risk people whose blood pressure was kept lower than the recommended level had a significant reduction in mild cognitive impairment (MCI), the precursor to dementia.…
New Alzheimer’s Drug Slows Memory Loss in Early Trial Results
July 25th, 2018
The long, discouraging quest for a medication that works to treat Alzheimer’s reached a potentially promising milestone on Wednesday. For the first time in a large clinical trial, a drug was able to both reduce the plaques in the brains of patients and slow the progression of dementia. More extensive trials will be needed to know if the new drug is truly effective, but if the results, presented Wednesday at the Alzheimer’s Association International Conference in Chicago, are borne out, the drug may be the first to successfully attack both the brain changes and the symptoms of Alzheimer’s.…
Hormone Levels Likely Influence A Woman’s Risk Of Alzheimer’s, But How?
July 23rd, 2018
There’s new evidence that a woman’s levels of female sex hormones, including estrogen and progesterone, can influence her risk of Alzheimer’s and other forms of dementia. Women are less likely to develop dementia later in life if they begin to menstruate earlier, go through menopause later, and have more than one child, researchers reported Monday at the Alzheimer’s Association International Conference in Chicago. And recent studies offer hints that hormone replacement therapy, which fell out of favor more than a decade ago, might offer a way to protect a woman’s brain if it is given at the right time, the researchers said. …
Women bear Alzheimer’s burden; researchers are trying to discover why
July 23rd, 2018
At the Alzheimer’s Association International Conference in Chicago this week, researchers are exploring biological and social differences that might explain why more women than men develop Alzheimer’s and other types of dementia.…
Caps’ TJ Oshie Shares Cup With Father Who Has Alzheimer’s
June 8th, 2018
In an emotional interview following the Caps’ Stanley Cup victory, T.J. Oshie said the win was for his father who is suffering from Alzheimer’s disease. “T.J. Oshie found his father on the ice amid the jubilant madness of the Washington Capitals’ postgame celebration and wrapped him in a fierce hug. Five years after he was diagnosed with Alzheimer’s disease, Tim Oshie’s memory is inconsistent and cloudy. Anyone who saw the depth of emotion in his Stanley Cup-winning son’s eyes Thursday night will never forget it.”…
Kaiser health news discussion on living well with dementia
February 7th, 2018
Please join Kaiser Health News on Tuesday, Feb. 13, from 12:30 to 2:00 p.m. ET for an informative and important discussion about improving care and services for people with dementia and supporting their caregivers.…
‘Doctors Speak Out’ Panelists Optimistic on Alzheimer’s
December 3rd, 2014
DECEMBER 10, 2014—There is more reason to feel hopeful about future prospects for Alzheimer’s treatment and prevention as research continues to yield important new insights about the disease, Georgetown University Medical Center (GUMC) experts agreed at a recent event.…
